Clinical Trial Update: Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study examining a single 14C-labeled dose of risedronate or alendronate followed by a weekly unlabeled dose in people with osteopenia or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Actonel (risedronate)
• FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: Warner Chilcott | Conditions: Osteopenia, Osteoporosis | Phase 1 | Status: COMPLETED